JPS57109724A - Novel hapten antigen and its preparation - Google Patents
Novel hapten antigen and its preparationInfo
- Publication number
- JPS57109724A JPS57109724A JP18410580A JP18410580A JPS57109724A JP S57109724 A JPS57109724 A JP S57109724A JP 18410580 A JP18410580 A JP 18410580A JP 18410580 A JP18410580 A JP 18410580A JP S57109724 A JPS57109724 A JP S57109724A
- Authority
- JP
- Japan
- Prior art keywords
- serum albumin
- carrier substance
- immunogenic carrier
- compound
- azepin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18410580A JPS57109724A (en) | 1980-12-26 | 1980-12-26 | Novel hapten antigen and its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18410580A JPS57109724A (en) | 1980-12-26 | 1980-12-26 | Novel hapten antigen and its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS57109724A true JPS57109724A (en) | 1982-07-08 |
Family
ID=16147473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP18410580A Pending JPS57109724A (en) | 1980-12-26 | 1980-12-26 | Novel hapten antigen and its preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57109724A (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05281225A (ja) * | 1991-08-26 | 1993-10-29 | Merck & Co Inc | N−置換アゼチジノンによるpmnエラスターゼの阻害を評価するアッセイ |
EP0583820A1 (en) * | 1992-08-07 | 1994-02-23 | Johnson & Johnson Clinical Diagnostics, Inc. | Novel carbamazepine hapten analogues |
EP0584854A1 (en) * | 1992-08-07 | 1994-03-02 | Johnson & Johnson Clinical Diagnostics, Inc. | Immunoassay using carbamazepine analogues labelled with horseraddish peroxidase |
US5543311A (en) * | 1992-08-07 | 1996-08-06 | Johnson & Johnson Clinical Diagnostics, Inc. | Labeled carbamazepine hapten analogues for competitive enzyme immunoassays |
US5578457A (en) * | 1992-08-07 | 1996-11-26 | Johnson & Johnson Clinical Diagnostics, Inc. | Immunoassays with novel labeled carbamazepine hapten analogues |
EP1132097A2 (en) * | 1993-10-15 | 2001-09-12 | ConjuChem, Inc. | Cellular and serum protein anchors and conjugates |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5287223A (en) * | 1976-01-12 | 1977-07-20 | Syva Co | Production of hapten compound derivative |
-
1980
- 1980-12-26 JP JP18410580A patent/JPS57109724A/ja active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5287223A (en) * | 1976-01-12 | 1977-07-20 | Syva Co | Production of hapten compound derivative |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05281225A (ja) * | 1991-08-26 | 1993-10-29 | Merck & Co Inc | N−置換アゼチジノンによるpmnエラスターゼの阻害を評価するアッセイ |
EP0583820A1 (en) * | 1992-08-07 | 1994-02-23 | Johnson & Johnson Clinical Diagnostics, Inc. | Novel carbamazepine hapten analogues |
EP0584854A1 (en) * | 1992-08-07 | 1994-03-02 | Johnson & Johnson Clinical Diagnostics, Inc. | Immunoassay using carbamazepine analogues labelled with horseraddish peroxidase |
US5395933A (en) * | 1992-08-07 | 1995-03-07 | Eastman Kodak Company | Carbamazepine hapten analogues |
US5543311A (en) * | 1992-08-07 | 1996-08-06 | Johnson & Johnson Clinical Diagnostics, Inc. | Labeled carbamazepine hapten analogues for competitive enzyme immunoassays |
US5578457A (en) * | 1992-08-07 | 1996-11-26 | Johnson & Johnson Clinical Diagnostics, Inc. | Immunoassays with novel labeled carbamazepine hapten analogues |
EP1132097A2 (en) * | 1993-10-15 | 2001-09-12 | ConjuChem, Inc. | Cellular and serum protein anchors and conjugates |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0157643A3 (en) | Antibodies to human interleukin-2 induced by synthetic polypeptides | |
ES467190A1 (es) | Un procedimiento para la produccion de un reactivo para pruebas inmunologicas. | |
AU591054B2 (en) | Pre-S gene coded peptide hepatitis B immunogens, vaccines and diagnostics | |
IE822629L (en) | N-aminoalkyl iodothyronines | |
ZA893284B (en) | Peptide analogs and their use as haptens to elicit catalytic antibodies | |
CA2320488A1 (en) | Strategically modified hepatitis b core proteins and their derivatives | |
US4259233A (en) | β-Galactosyl-umbelliferone-labeled protein and polypeptide conjugates | |
AU564620B2 (en) | Peptides and protein-peptide complexes | |
AU4548189A (en) | Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof | |
JPS57109724A (en) | Novel hapten antigen and its preparation | |
EP0263761A3 (en) | Non-a, non-b, hepatitis antigen | |
EP0095873A3 (en) | Region-specific determinants for vitamin k dependent bone protein | |
NO900758D0 (no) | Fremgangsmaate for fremstilling av hybridprotein. | |
AU8100291A (en) | Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies | |
Gaur et al. | Enzyme-linked immunosorbent assay to detect anti-sea nettle venom antibodies | |
IE851279L (en) | Conjugates of monovalent carboxylic ionophores | |
WO1996040664A3 (en) | Preparation of immunogens and other conjugates of drugs | |
JPS5799533A (en) | Hapten antigen and its synthetic intermediate | |
JPS5665828A (en) | Antitumor agent | |
ZA868271B (en) | Method for the preparation of immunoglobulins suitable for intravenous administration | |
IE43231L (en) | N-(substituted benzyl) alkanediamines | |
JPS57192320A (en) | Novel haptenic antigen and its preparation | |
RU95104325A (ru) | Коньюгаты антител с улучшенными свойствами | |
JPS57142967A (en) | N-(acylthioalkanoyloxy)succinimide and its use | |
AU7145087A (en) | Tumor-associated antigens (mol wt 160,000-170,000; 44,000-46,000; 29,000-35,000) |